Opiod receptor types and dependence

Folia Pharmacologica Japonica

Volumn 109, Issue 4, 1997, Pages 165-173

  Suzuki, Tsutomu ^a   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA ENDORPHIN; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; DYNORPHIN A; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; KETAZOCINE; LEUCINE ENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ANALGESIA; CANCER PAIN; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; HUMAN; LIMBIC CORTEX; LOCUS CERULEUS; NEUROPHARMACOLOGY; PSYCHOPHARMACOLOGY; REVIEW; ANIMAL; CLASSIFICATION; OPIATE ADDICTION; PHYSIOLOGY;

ANIMALS; HUMANS; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0031114345     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.109.165     Document Type: Review

References (49)

1. Suzuki T: Pharmacological studies on drug dependence in rodents: Opioids and CNS depressants dependence. Jpn J Pharmacol 52, 1-10 (1990)
2. Wood PL, Charleson SE, Lane D and Hudgin RL: Multiple opiate receptors: Differential binding of μ, κ and δ agonists. Neuropharmacology 20, 1215-1220 (1981)
3. Cowan A, Zhu XZ, Mosberg HI, Omnaas JR and Porreca F: Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther 246, 950-955 (1988)
4. Moskowitz AS and Goodman RR: Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL /6BY and CXBK (opioid receptor-deficient) mice. Brain Res 360, 108-116 (1985)
5. Clin Neurosci 13, 739 (1995)
6. Suzuki T, Hayashi Y and Misawa M: The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse. Life Sci 50, 849-856 (1992)
7. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Meur LM, Dolle P, et al: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383, 819-823 (1996)
8. Maldonado R, Stinus L and Koob GF: Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261, 669-677 (1992)
9. Katada T and Ui M: Direct modification of membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of membrane protein. Proc Natl Acad Sci USA 79, 3129-3133 (1982)
10. Funada M, Narita M, Suzuki T and Misawa M: Effect of pretreatment with pertussis toxin on the development of physical dependence on morphine. Naunyn Schmiedebergs Arch Pharmacol 348, 88-95 (1993)
11. Funada M, Suzuki T, Sugano Y, Tsubai M, Misawa M, Ueda H and Misu Y: Role of β -adrenoceptors in the expression of morphine withdrawal signs. Life Sci 54, PL113-118 (1994)
12. Aghajanian GK: Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276, 186-188 (1978)
13. Nestler EJ: Under siege: the brain on opiates. Neuron 16, 897-900 (1996)
14. Narita M, Makimura M, Feng Y, Hoskins B and Ho IK: Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Eur J Pharmacol 650, 175-179 (1994)
15. Tokuyama S, Feng Y, Wakabayashi H and Ho IK: Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. Eur J Pharmacol 284, 101-107 (1995)
16. Gold ME, Redmond DE Jr and Kleber HD: Clonidine in opiate withdrawal. Lancet ii, 599-602 (1978)
17. Trujillo K and Akil H: Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87 (1991)
18. Makimura M, Sugimoto H, Shinomiya K, Kabasawa Y and Fukuda H: Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence. J Toxicol Sci 21, 135-141 (1996)
19. Narita M, Mizoguchi H, Kampine JF and Tseng LF: Role of protein kinase C in desensitization of spinal δ -opioid-mediated antinociceptioh in the mouse. Br J Pharmacol 118, 1829-1835 (1996)
20. Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T and Nagase H: Effects of a highly selective nonpeptide δ opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice. Life Sci 57, 155-168 (1995)
21. Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T and Nagase H: Effect of the highly selective nonpeptide δ opioid receptor agonist, TAN-67, on morphine-induced place preference in mice. J Pharmacol Exp Ther 279, 177-185 (1996)
22. Gmerek DE, Dykstra LA and Woods JH: Kappa opioids in rhesus monkeys.III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242, 428-436 (1987)
23. Deneau G, Yanagita T and Seevers MH: Self-administration of psychoactive substances by the monkeys. Psychopharmacologia 16, 30-48 (1969)
24. Yanagita T: Prediction of drug abuse liability from animal studies. In Methods of Assessing the Reinforcing Properties of Abused Drugs, Edited by Bozarth MA, pp 189-198, Springer-Verlag, New York (1987)
25. Spyraki C: Drug reward studied by the use of place conditioning in rats. In The Psychopharmacology of Addiction, Edited by Lader M, pp 97-114, Oxford Medical Publications, New York (1988)
26. Suzuki T, Masukawa Y and Misawa M: Drug interaction in reinforcing properties of over-the-counter cough syrups. Psychopharmacology (Berlin) 102, 438-442 (1990)
27. Suzuki T, Masukawa Y, Shiozaki Y and Misawa M: Potentiation of pentazocine conditioned place preference by tripelennamine in rats. Psychopharmacology (Berlin) 105, 9-12 (1991)
28. Suzuki T, Funada M, Narita M, Misawa M and Nagase H: Morphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes. Brain Res 602, 45-52 (1993)
29. Wood PL and Pasternak GW: Specific μ2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine. Neurosci Lett 37, 291-293 (1982)
30. Bozarth MA and Wise RA: Heroin reward is dependent on a dopaminergic substrate. Life Sci 29, 1881-1886 (1981)
31. Mansour A, Khachaturian H, Lewis ME, Akil H and Watson SJ: Anatomy of CNS opioid receptors. Trends Neurosci 11, 308-314 (1988)
32. Funada M, Suzuki T and Misawa M: Role of mesolimbic dopamine system in morphine dependence. Ann Psychiatry 5, 223-237 (1995)
33. Goeders NE, Lane JD and Smith JE: Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 20, 451-455 (1984)
34. Suzuki T, Funada M, Narita M, Misawa M and Nagase H: Pertussis toxin abolishes μ- and δ -opioid agonist-induced place preference. Eur J Pharmacol 205, 85-88 (1991)
35. Suzuki T, Yoshiike M, Mizoguchi H, Kamei J, Misawa M and Nagase H: Blockade of δ -opioid receptors prevents morphine-induced place preference in mice. Jpn J Pharmacol 66, 131-137 (1994)
36. Suzuki T, Tsuji M, Mori T, Ikeda H, Misawa M and Nagase H: Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by δ opioid receptor subtypes in mice. Brain Res 744, 327-334 (1997)
37. Suzuki T, Tsuji M, Mori T, Misawa M and Nagase H: The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of δ 1 and δ 2 opioid receptor agonists in mice. Psychopharmacology (Berlin) 124, 211-218 (1996)
38. Tang AH and Collins RJ: Behavioral effects of a novel kappa opioid analgesic, U-50488H, in rats and rhesus monkeys. Psychopharmacology (Berlin) 85, 309-314 (1985)
39. Mucha RF and Herz A: Motivational properties of kappa and mu opioid receptor agonists studies with place and taste preference conditioning. Psychopharmacology (Berlin) 86, 274-280 (1985)
40. Funada M, Suzuki T, Narita M, Misawa M and Nagase H: Blockade of morphine reward through the activation of κ -opioid receptors in mice. Neuropharmacology 32, 1315-1323 (1993)
41. Spanagel R, Herz A and Shippenberg TS: Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89, 2046-2050 (1992)
42. Suzuki T, Narita M, Takahashi Y, Misawa M and Nagase H: Effects of norbinaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur J Pharmacol 213, 91-97 (1992)
43. Green PG and Lee NM: Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effects of route of administration. Eur J Pharmacol 145, 267-272 (1988)
44. Suzuki T, Fukagawa Y, Yoshii T and Yanaura S: Effect of opioid agonist-antagonist interaction on morphine dependence in rats. Life Sci 42, 2729-2737 (1988)
45. Narita M, Suzuki T, Funada M, Misawa M and Nagase H: Involvement of δ -opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice. Psychopharmacology (Berlin) 111, 423-426 (1993)
46. Suzuki T, Tsuji M, Mori T, Misawa M and Nagase H: Effect of naltrindole on the development of physical dependence on morphine in mice: a behavioral and biochemical study. Life Sci 57, PL247-252 (1995)
47. Suzuki T, Kishimoto Y and Misawa M: Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci 59, 1667-1674 (1996)